BiotechTube

olmesartan

Pre-clinicalCompleted
0 watching 0 views this week๐Ÿ’ค Quiet
23
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Vascular Function

Conditions

Vascular Function, Exercise Training

Trial Timeline

Dec 1, 2009 โ†’ Dec 1, 2011

NCT ID
NCT01053026

About olmesartan

olmesartan is a pre-clinical stage product being developed by Daiichi Sankyo for Vascular Function. The current trial status is completed. This product is registered under clinical trial identifier NCT01053026. Target conditions include Vascular Function, Exercise Training.

Hype Score Breakdown

Clinical
5
Activity
2
Company
10
Novelty
2
Community
1

Clinical Trials (2)

NCT IDPhaseStatus
NCT01053026Pre-clinicalCompleted
NCT00098137Phase 3Completed

Competing Products

20 competing products in Vascular Function

See all competitors
ProductCompanyStageHype Score
CLS-AX + Anti-VEGFClearside BiomedicalPhase 1/2
33
CLS-AX + AfliberceptClearside BiomedicalPhase 2
44
Eylea + ALT-L9AlteogenPhase 1
33
Dulaglutide + PlaceboEli LillyPhase 3
77
raloxifene + placeboEli LillyPhase 3
77
EvacetrapibEli LillyPhase 1
33
Orforglipron + PlaceboEli LillyPhase 3
77
UBX1325 injection 50 ฮผL + EYLEAยฎ (aflibercept) Injection 2 mg (0.05mL)Unity BiotechnologyPhase 2
44
Prasugrel (CS-747) + ClopidogrelEli LillyPhase 2
52
Rosuvamibe + MonorovaYuhanApproved
85
Efficacy and safety of combination therapy of moderate-intensity statin and ezetimibe compared to high-intensity statinYuhanApproved
85
Rosuvamibe + MonorovaYuhanApproved
85
DS-7080a + RanibizumabDaiichi SankyoPhase 1
33
Prasugrel (Crushed tablets) + Prasugrel (Integral tablets)Daiichi SankyoApproved
85
Avacincaptad PegolAstellas PharmaPhase 1
33
Avacincaptad Pegol + Avastin + Lucentis + EyleaAstellas PharmaPhase 2
52
LexiscanAstellas PharmaPhase 2
52
YM872 (zonampanel)Astellas PharmaPhase 2
52
Avacincaptad Pegol + LucentisAstellas PharmaPhase 2
52
mirabegron + tamsulosinAstellas PharmaPhase 1
33

Other Products from Daiichi Sankyo

Olmesartan medoxomil + Olmesartan medoxomil/hydrochlorothiazide + HydrochlorothiazideApproved
85
OAC aloneApproved
85
olmesartan medoxomil + Placebo + losartan potassiumApproved
85
Prasugrel + ClopidogrelApproved
85
Diet+pravastatinApproved
85